Found: 29
Select item for more details and to access through your institution.
Joint Effect of Hypertension and APOE Genotype on CSF Biomarkers for Alzheimer's Disease.
- Published in:
- Journal of Alzheimer's Disease, 2010, v. 20, n. 4, p. 1083, doi. 10.3233/JAD-2010-091198
- By:
- Publication type:
- Article
Additional Value of CSF Amyloid-β<sub> {40}</sub> Levels in the Differentiation between FTLD and Control Subjects.
- Published in:
- Journal of Alzheimer's Disease, 2010, v. 20, n. 2, p. 445, doi. 10.3233/JAD-2010-1392
- By:
- Publication type:
- Article
CSF Biomarkers in Alzheimer's Disease and Controls: Associations with APOE Genotype are Modified by Age.
- Published in:
- Journal of Alzheimer's Disease, 2009, v. 16, n. 3, p. 601, doi. 10.3233/JAD-2009-0999
- By:
- Publication type:
- Article
Circulating metabolites are associated with brain atrophy and white matter hyperintensities.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, n. 2, p. 205, doi. 10.1002/alz.12180
- By:
- Publication type:
- Article
LDL cholesterol and uridine levels in blood are potential nutritional biomarkers of AD progression: The NUDAD project: Biomarkers (non‐neuroimaging) / Novel biomarkers.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.043108
- By:
- Publication type:
- Article
P3‐607: DIETARY INTAKE AND NUTRIENT LEVELS OF B‐VITAMINS AND OMEGA‐3 FATTY ACIDS ARE DIFFERENTIALLY ASSOCIATED IN SUBJECTIVE COGNITIVE DECLINE, MILD COGNITIVE IMPAIRMENT AND ALZHEIMER'S DISEASE: THE NUDAD PROJECT.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P1209, doi. 10.1016/j.jalz.2019.06.3645
- By:
- Publication type:
- Article
P3‐617: NUTRITIONAL INTAKE IN SUBJECTIVE COGNITIVE DECLINE: ROOM FOR IMPROVEMENT?
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1366, doi. 10.1016/j.jalz.2018.06.1984
- By:
- Publication type:
- Article
P2‐645: IMPAIRED OLFACTORY AND GUSTATORY FUNCTIONING IN PATIENTS WITH ALZHEIMER'S DISEASE AND MILD COGNITIVE IMPAIRMENT: THE NUDAD PROJECT.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P990, doi. 10.1016/j.jalz.2018.06.1341
- By:
- Publication type:
- Article
P2‐284: NUTRITIONAL MARKERS ASSOCIATED WITH CLINICAL PROGRESSION IN PATIENTS WITH MILD COGNITIVE IMPAIRMENT AND SUBJECTIVE COGNITIVE DECLINE: THE NUDAD STUDY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P789, doi. 10.1016/j.jalz.2018.06.973
- By:
- Publication type:
- Article
P1‐656: NUTRITIONAL STATUS AND BODY COMPOSITION OF PATIENTS WITH AD, MCI AND SUBJECTIVE COGNITIVE DECLINE: THE NUDAD PROJECT.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P593, doi. 10.1016/j.jalz.2018.06.668
- By:
- Publication type:
- Article
P1‐297: METABOLIC BLOOD‐BASED BIOMARKERS RELATE TO BRAIN ATROPHY AND WHITE MATTER HYPERINTENSITIES IN ALZHEIMER'S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P401, doi. 10.1016/j.jalz.2018.06.303
- By:
- Publication type:
- Article
Decreased mRNA expression of CCL5 [RANTES] in Alzheimer's disease blood samples.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2012, v. 50, n. 1, p. 61, doi. 10.1515/cclm.2011.731
- By:
- Publication type:
- Article
Tau and p-tau as CSF biomarkers in dementia: a meta-analysis.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2011, v. 49, n. 3, p. 353, doi. 10.1515/CCLM.2011.086
- By:
- Publication type:
- Article
PROFILING PERIPHERAL METABOLIC DYSREGULATION IN ALZHEIMER’S DISEASE: THE ADDED VALUE OF MULTIPLE SIGNATURES.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P1024, doi. 10.1016/j.jalz.2017.06.1439
- By:
- Publication type:
- Article
Neurogranin, a CSF biomarker for synaptic loss, predicts decline to dementia due to Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P326, doi. 10.1016/j.jalz.2015.07.471
- By:
- Publication type:
- Article
Are relations between ApoE genotype and ad-related pathology in nondemented elderly mediated by CSF apolipoproteins?
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P644, doi. 10.1016/j.jalz.2015.06.939
- By:
- Publication type:
- Article
Apolipoprotein a-1 is associated with decline in preclinical ad.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2014, v. 10, p. P195, doi. 10.1016/j.jalz.2014.04.232
- By:
- Publication type:
- Article
Discriminatory and predictive capabilities of enzyme-linked immunosorbent assay and multiplex platforms in a longitudinal Alzheimer’s disease study
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2013, v. 9, n. 3, p. 276, doi. 10.1016/j.jalz.2012.01.004
- By:
- Publication type:
- Article
CSF biomarkers predict cognitive decline in Alzheimer's disease
- Published in:
- 2009
- By:
- Publication type:
- Abstract
P3-079: CSF biomarker levels, APOE genotype and the effect of aging
- Published in:
- 2008
- By:
- Publication type:
- Abstract
Standardization of assay procedures for analysis of the CSF biomarkers amyloid B(1-42), Tau, and phosphorylated Tau in Alzheimer's disease: report of an international workshop.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
Standardization of Assay Procedures for Analysis of the CSF Biomarkers Amyloid β<sub>(1-42)</sub>, Tau, and Phosphorylated Tau in Alzheimer's Disease: Report of an International Workshop.
- Published in:
- International Journal of Alzheimer's Disease, 2010, v. 2010, p. 1, doi. 10.4061/2010/635053
- By:
- Publication type:
- Article
Diagnostic Impact of CSF Biomarkers in a Local Hospital Memory Clinic.
- Published in:
- Dementia & Geriatric Cognitive Disorders, 2010, v. 29, n. 6, p. 491, doi. 10.1159/000313534
- By:
- Publication type:
- Article
Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer Disease.
- Published in:
- JAMA Neurology, 2015, v. 72, n. 11, p. 1275, doi. 10.1001/jamaneurol.2015.1867
- By:
- Publication type:
- Article
Associations Between Cerebral Small-Vessel Disease and Alzheimer Disease Pathology as Measured by Cerebrospinal Fluid Biomarkers.
- Published in:
- JAMA Neurology, 2014, v. 71, n. 7, p. 855, doi. 10.1001/jamaneurol.2014.754
- By:
- Publication type:
- Article
Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer's disease in a memory clinic cohort.
- Published in:
- Alzheimer's Research & Therapy, 2015, v. 7, n. 1, p. 1, doi. 10.1186/s13195-015-0142-1
- By:
- Publication type:
- Article
A Suboptimal Diet Is Associated with Poorer Cognition: The NUDAD Project.
- Published in:
- Nutrients, 2020, v. 12, n. 3, p. 703, doi. 10.3390/nu12030703
- By:
- Publication type:
- Article
Dietary Patterns Are Related to Clinical Characteristics in Memory Clinic Patients with Subjective Cognitive Decline: The SCIENCe Project.
- Published in:
- Nutrients, 2019, v. 11, n. 5, p. 1, doi. 10.3390/nu11051057
- By:
- Publication type:
- Article
Associations of AD Biomarkers and Cognitive Performance with Nutritional Status: The NUDAD Project.
- Published in:
- Nutrients, 2019, v. 11, n. 5, p. 1, doi. 10.3390/nu11051161
- By:
- Publication type:
- Article